Toll Free: 1-888-928-9744

EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026

Published: Jul 10, 2017 | Pages: 40 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026

Summary

Type 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body's inability to make use of available insulin along with relative insulin deficiency. T2D constitutes approximately 90-95% of all diabetes cases around the world, while type 1 diabetes and gestational diabetes make up the remaining 5-10% of cases. Lifestyle factors such as obesity, physical inactivity, and dietary habits are modifiable risk factors, and can therefore be controlled or prevented. Non-modifiable risk factors such as race/ethnicity, family history, and advancing age can also put a person at high risk for developing the disease. T2D is also associated with several comorbidities including chronic kidney disease, cardiovascular disease, hypertension, and dyslipidemia.

In the 7MM, GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of T2D from 56,060,328 diagnosed prevalent cases in 2016 to 77,823,223 diagnosed prevalent cases in 2026, with an annual growth rate (AGR) of 3.88% during the forecast period. The US will have the highest number of diagnosed prevalent cases of T2D among the 7MM throughout the forecast period, while Italy will have the lowest.

GlobalData's epidemiological forecast for the diagnosed prevalence of T2D in the 7MM is supported by longitudinal historical data, which provide detailed insights into the epidemiology of the disease in each market, from studies conducted in these respective countries. GlobalData epidemiologists used nationally representative, country-specific studies published in peer-reviewed journals or national healthcare databases to forecast the prevalent cases of diagnosed T2D in all of the 7MM. GlobalData epidemiologists also segment the diagnosed prevalent cases of T2D in each country by age and sex, and into the major comorbidities of T2D.

Scope

- The Type 2 Diabetes (T2D) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of T2D in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of T2D segmented by age (for ages 20 years and older) and sex in these markets. Additionally, the report provides a forecast of the major comorbidities of T2D, such as chronic kidney disease, cardiovascular disease, obesity, hypertension, and dyslipidemia in the diagnosed T2D prevalent pool.
- The T2D epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons To Buy

The T2D EpiCast report will allow you to - 
- Develop business strategies by understanding the trends shaping and driving the global T2D market.
- Quantify patient populations in the global T2D market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for T2D therapeutics in each of the markets covered.
- Identify the percentage of T2D diagnosed prevalent cases by age, sex, and major comorbid disorders.
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 3 1.2 List of Figures 3 2 Executive Summary 4 2.1 Related Reports 5 2.2 Upcoming Reports 6 3 Epidemiology 7 3.1 Disease Background 7 3.2 Risk Factors and Comorbidities 7 3.3 Global and Historical Trends 8 3.4 Forecast Methodology 10 3.4.1 Sources 10 3.4.2 Forecast Assumptions and Methods 16 3.4.3 Diagnosed Prevalent Cases of T2D 16 3.5 Epidemiological Forecast for T2D (2016-2026) 23 3.5.1 Diagnosed Prevalent Cases of T2D 23 3.5.2 Age-Specific Diagnosed Prevalent Cases of T2D 24 3.5.3 Sex-Specific Diagnosed Prevalent Cases of T2D 25 3.5.4 Comorbidities Among the Diagnosed Prevalent Cases of T2D 26 3.6 Discussion 31 3.6.1 Epidemiological Forecast Insight 31 3.6.2 Limitations of Analysis 31 3.6.3 Strengths of Analysis 32 4 Appendix 34 4.1 Bibliography 34 4.2 About the Authors 38 4.2.1 Epidemiologist 38 4.2.2 Reviewers 38 4.2.3 Global Director of Therapy Analysis and Epidemiology 39 4.2.4 Global Head and EVP of Healthcare Operations and Strategy 39 4.3 About GlobalData 40 4.4 Contact Us 40 4.5 Disclaimer 40
List of Tables
Table 1: Risk Factors and Comorbidities for T2D. 8 Table 2: 7MM, Diagnosed Prevalent Cases of T2D, Ages 20 Years, Both Sexes, N, Selected Years 2016-2026 24 List of Figures
Figure 1: 7MM, Diagnosed Prevalent Cases of T2D, Both Sexes, Ages 20 Years, 2016 and 2026 5 Figure 2: 7MM, Age-Standardized Diagnosed Prevalence (%) of T2D, Men, Ages 20 Years, 2006-2026 9 Figure 3: 7MM, Age-Standardized Diagnosed Prevalence (%) of T2D, Women, Ages 20 Years, 2006-2026 10 Figure 4: 7MM, Sources Used and Not Used, Diagnosed Prevalent Cases of T2D 11 Figure 5: 7MM, Sources Used, Prevalent Cases of CKD Among the Diagnosed Prevalent Cases of T2D 12 Figure 6: 7MM, Sources Used, Prevalent Cases of CVD Among the Diagnosed Prevalent Cases of T2D 13 Figure 7: 7MM, Sources Used, Prevalent Cases of Obesity Among the Diagnosed Prevalent Cases of T2D 14 Figure 8: 7MM, Sources Used, Prevalent Cases of Hypertension Among the Diagnosed Prevalent Cases of T2D 15 Figure 9: 7MM, Sources Used, Prevalent Cases of Dyslipidemia Among the Diagnosed Prevalent Cases of T2D 16 Figure 10: 7MM, Age-Specific Diagnosed Prevalent Cases of T2D, Ages 20 Years, Both Sexes, N, 2016 25 Figure 11 : 7MM, Sex-Specific Diagnosed Prevalent Cases of T2D, Ages 20 Years, N, 2016 26 Figure 12: 7MM, Prevalent Cases of CKD Among the Diagnosed Prevalent Cases of T2D, Ages 20 Years, Both Sexes, N, 2016 27 Figure 13: 7MM, Prevalent Cases of CVD Among the Diagnosed Prevalent Cases of T2D, Ages 20 Years, Both Sexes, N, 2016 28 Figure 14: 7MM, Prevalent Cases of Obesity Among the Diagnosed Prevalent Cases of T2D, Ages 20 Years, Both Sexes, N, 2016 29 Figure 15: 7MM, Prevalent Cases of Hypertension Among the Diagnosed Prevalent Cases of T2D, Ages 20 Years, Both Sexes, N, 2016 30 Figure 16: 7MM, Prevalent Cases of Dyslipidemia Among the Diagnosed Prevalent Cases of T2D, Ages 20 Years, Both Sexes, N, 2016 31



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growt

Read More...

Global adhesives & sealants market size is expected to reach USD 43.19 billion by 2020, as per a new research report by Radiant Insights, Inc. Strong demand from packaging, construction and automotive industries is expected drive adhesives and sealan

Read More...
Choose License Type
Single User - US $3995
Multi User - US $7990
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify